A New Therapeutic Approach Based on Silymarin in the Treatment of Breast Cancer

One of the goals of nanotechnology is to mount molecules and drugs on carrier materials, and then send and release them into the cell. Since so far, the researches carried out on the loading of the active substance of silybum marianum, silybin in in lipid nanocarriers have been very few. Therefore, in this research, the effect of silybin lipid nano-system on BT-474 cancer cell line has been investigated. Methodology: By preparing a stock solution of silybin in in isopropyl and PBS solvents, the wavelength at which silybin has the most absorption in the range of 200 to 700 was prepared by spectrophotometric method. To make nanoliposomes containing silybin in, the thin layer hydration method was used. The MTT method was used to check the toxicity of constructed lipid system and to determine the percentage of cell viability. Results: The results of drug-free nanoliposome toxicity and its comparison with the control show that drug-free nanoliposome is not toxic on BT-474 cells and does not cause side effects on body cells. Conclusion: The data obtained from investigating the effect of silybin in and liposomal nanoparticles carrying silybin in on BT-474 breast cancer cell line by MTT method, in addition to confirm the anticancer properties of silybin showed the anticancer properties of silybin loaded in nanoparticles. The lipid system is more than its free state.